Southern California Reproductive Center

What Southern California Reproductive Center does

Southern California Reproductive Center (SCRC) is a private, physician-founded fertility medical practice operating four clinic locations across Southern California: Beverly Hills (headquarters), Santa Barbara, Pasadena, and Ventura. Founded in 2000 by reproductive medicine pioneers Dr. Mark Surrey and Dr. Hal C. Danzer, the practice is staffed by five board-certified reproductive endocrinologists and supported by an on-site clinical laboratory, embryology lab directors, nurse practitioners, physician assistants, and licensed acupuncturists. SCRC serves a diverse patient base including heterosexual couples facing infertility, LGBTQ+ individuals and couples, single parents by choice, oncology patients requiring urgent fertility preservation, and intended parents pursuing donor services or gestational surrogacy.

The practice delivers a comprehensive fertility service portfolio including intrauterine insemination (IUI), in vitro fertilization (IVF), egg freezing and fertility preservation, male fertility evaluation and treatment, donor egg/sperm and gestational surrogacy coordination, and a full suite of embryology laboratory services (ICSI, embryo culture, vitrification cryopreservation, preimplantation genetic testing). Its embryology laboratory is equipped with time-lapse embryo imaging, electronic witnessing (RFID/barcode) systems, HEPA and VOC air filtration, low-oxygen 5% O2 culture environments, and 24-hour monitoring. In 2025-2026, SCRC integrated with the Nucleus IVF+ Network to provide expanded genetic carrier screening and embryo analysis covering more than 2,000 rare inherited conditions.

SCRC generates revenue through a transaction-based medical services model, with procedure-specific billing for IVF cycles, IUI, egg freezing, donor services, and surrogacy coordination, supplemented by professional services fees for consultations and embryology lab work. The practice participates as an in-network provider across a broad set of PPO and HMO plans (Aetna, Anthem Blue Cross, Blue Shield, Cigna, United Healthcare) and fertility benefits programs (Progyny, Carrot, Maven, Kindbody), and partners with Advanced Reproductive Care (ARC), CapexMD, and The Egg Fund to offer patient financing. Marketing is driven by educational content, webinars, social media, patient testimonials, and physician media authority rather than paid advertising at scale.

Name

Southern California Reproductive Center

Legal name

Southern California Reproductive Center

Website

https://scrcivf.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

51–100 employees

Short description

Southern California Reproductive Center is a physician-founded private fertility practice operating four Southern California clinics, offering IVF, IUI, egg freezing, donor services, surrogacy, and advanced embryology lab services to individuals and couples facing infertility or seeking family building.

Ownership category

akta.pro rank

Product category

Reproductive Medicine and Fertility Services

NAICS

Family Planning Centers (62141)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industry

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC)

Keywords

• Fertility treatment services
• In vitro fertilization
• Egg freezing preservation
• Reproductive medicine
• Embryology laboratory

Headquarters

HQ city

Beverly Hills

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Fertility Treatment Procedures: Medical practice revenue from fertility treatments including IUI, IVF, egg freezing, donor services, surrogacy coordination, and male fertility treatments. Procedures are typically billed individually or as treatment packages.
2. Consultation Services: Initial and follow-up consultations with fertility specialists, including diagnostic testing and treatment planning.
3. Laboratory Services: Embryology lab services including IVF, ICSI, embryo culture, genetic testing (PGT), embryo freezing/storage, and sperm preparation.
4. Fertility Financing: Partnership with Advanced Reproductive Care (ARC) and other financing programs to provide payment plans and financing options for patients, generating revenue through financial coordination.
5. Insurance Reimbursement: Accepts various PPO and HMO insurance plans including Aetna, Anthem Blue Cross, Blue Shield, Cigna, United Healthcare, and others. Revenue received through insurance claims and patient co-pays.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels9 records

Core offering

Southern California Reproductive Center delivers comprehensive fertility and assisted reproductive technology (ART) services through four Southern California clinics. Offerings span intrauterine insemination (IUI), in vitro fertilization (IVF), egg freezing and fertility preservation, male fertility evaluation and treatment, donor egg/sperm and gestational surrogacy coordination, and on-site embryology lab services (ICSI, PGT, vitrification, embryo storage). Care is delivered by five board-certified reproductive endocrinologists supported by a world-class embryology laboratory.

Product overview

Southern California Reproductive Center offers a comprehensive suite of fertility treatments centered around its core IVF and assisted reproductive technology (ART) services. The main product portfolio includes Intrauterine Insemination (IUI), In Vitro Fertilization (IVF), Egg Freezing & Fertility Preservation, Male Fertility Treatment with Semen Analysis, Donor Services & Surrogacy, and Embryology Lab Services. These services are supported by an on-site advanced embryology laboratory and augmented by the Nucleus IVF+ genetic analysis partnership for expanded embryo screening capabilities. The center provides treatment across four Southern California locations: Beverly Hills, Santa Barbara, Pasadena, and Ventura.

Differentiator

Problem solved

Functional benefit

Products and services

• Intrauterine Insemination (IUI) A low-complexity fertility treatment where prepared sperm is placed directly into the uterus during ovulation to increase chances of fertilization. Used for mild male factor infertility, unexplained infertility, or same-sex couples using donor sperm.
• In Vitro Fertilization (IVF) A highly effective assisted reproductive technology where eggs are retrieved from ovaries, fertilized with sperm in a specialized lab, and the healthiest embryo(s) are transferred into the uterus. Allows for advanced testing, embryo freezing, and family-building options.
• Egg Freezing and Fertility Preservation Oocyte cryopreservation allowing individuals to preserve healthy eggs at their current age for future use. The process involves hormone stimulation, egg retrieval, and cryopreservation using vitrification techniques.
• Male Fertility Treatment and Semen Analysis Comprehensive care for male reproductive health including semen analysis evaluating sperm count, motility, and morphology, along with treatment options including supplements, medications, surgical options, and ICSI during IVF.
• Donor Services and Surrogacy Comprehensive donor egg, donor sperm, and gestational surrogacy programs. Includes donor screening, matching services, and coordination of medical, legal, and emotional components for family building.
• Embryology Lab Services State-of-the-art embryology laboratory services including IVF, ICSI, embryo freezing (vitrification), preimplantation genetic testing (PGT), embryo storage and thawing, and sperm preparation and cryopreservation.
• Nucleus IVF+ Genetic Analysis Advanced genetic screening and analysis services through partnership with Nucleus Genomics, offering expanded carrier screening (Preview) and embryo analysis (Embryo) covering over 2,000 rare inherited conditions including heart disease, diabetes, cystic fibrosis, PKU, and hereditary cancer syndromes (HBOC, Lynch syndrome).

Quantifiable outcome

• Average live birth rate per donor egg transfer cycle nationally: ~53% (CDC ART data)
• +3 more outcomes

Named customers8 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Nucleus GenomicscoreTechnology or IntegrationSCRC joined the Nucleus IVF+ Network, providing patients access to Nucleus' expanded carrier screening (Preview) and advanced embryo analysis (Embryo). The partnership integrates genetic testing directly into IVF care at all four SCRC California locations, covering 2,000+ rare inherited conditions including heart disease, diabetes, cystic fibrosis, PKU, and hereditary cancer syndromes (HBOC, Lynch syndrome).
• MyEggBankcoreTechnology or IntegrationSCRC holds MyEggBank affiliate status, providing access to one of North America's most prominent frozen egg bank networks with rigorous screening standards and extensive donor profiles for patient use in donor egg IVF cycles.
• Advanced Reproductive Care (ARC)coreOthersSCRC partners with ARC to offer fertility financing options, payment plans, and discount programs to help patients afford treatment costs while minimizing financial risk. ARC also handles pharmacy plans for fertility medications.
• The Egg FundminorOthersAdditional financial program available to SCRC patients for fertility treatment funding assistance.
• CapexMDminorOthersSpecialized fertility financing partner offering treatment loans and payment plans for SCRC patients.
• Flexible Care OptionminorOthersFlexible payment option available to SCRC patients for managing fertility treatment costs.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Kindbody: Tech-enabled fertility clinic network offering IVF, egg freezing, and family-building care across multiple U.S. locations with employer-benefit partnerships. Directly comparable as a multi-site fertility provider, though digitally native and PE-backed versus SCRC's physician-owned model.
• HRC Fertility: Long-established Southern California fertility practice with multiple locations across LA and Orange County. Direct geographic competitor offering the same core IVF, IUI, egg freezing, and PGT services in SCRC's home market.
• CCRM (Colorado Center for Reproductive Medicine): Large fertility clinic network with proprietary lab technology and multiple U.S. locations offering IVF, fertility preservation, and genetic testing. Closely comparable in full-service fertility offerings, advanced embryology labs, and a regional-clinic-to-network growth model.
• Shady Grove Fertility: One of the largest U.S. fertility practices with 30+ locations offering IVF, IUI, donor services, and shared-risk programs. Directly comparable in multi-location fertility care, advanced lab capabilities, and inclusive patient positioning.
• Boston IVF: Multi-location fertility practice network with full-service reproductive endocrinology offerings. Comparable as a regional-to-national fertility group with strong physician-led model and advanced lab capabilities.
• Prelude Fertility (Inception Fertility): National fertility network of clinics including MyEggBank and donor egg programs. SCRC's MyEggBank affiliate status makes Prelude a closely comparable operator in the donor egg and IVF space.
• RMA (Reproductive Medicine Associates of New Jersey/New York): Large fertility network with strong research orientation (e.g., pioneering mild stimulation IVF) and multiple U.S. locations. Comparable as a full-service fertility platform with academic-quality protocols and PGT capabilities.

Emerging players

• Extend Fertility: Egg freezing-focused fertility practice with a streamlined, modern brand targeting elective fertility preservation. Comparable as a fertility clinic serving similar elective preservation demand, though narrower in scope than SCRC's full-service offering.

Others

• Progyny: Employer-sponsored fertility benefits platform that directs patients to network clinics including SCRC. Listed as an accepted partner, Progyny represents both a demand channel and a strategic adjacency shaping how fertility care is purchased in the U.S.
• Genea Biomedx: Provider of ART lab equipment and consumables (e.g., Geri time-lapse incubators) used in advanced embryology labs. Comparable as an enabling technology vendor whose products underpin the embryology capabilities SCRC and other peers market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/SCRCIVF
• YouTubeyoutube.com/c/Scrcivf
• Facebookfacebook.com/SCRCivf
• Instagraminstagram.com/scrcivf
• TikToktiktok.com/@scrcivf
• Pinterestpinterest.com/scrcivf

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Southern California Reproductive Center